After a stellar 2024 for recovering small to mid caps sector, our experts scour the sector for more overlooked nuggets.

With two juniors entering trading halts, more gold M&A could be coming in 2024. With prices near record highs, 2025 looks ...

The owner of a fluorspar deposit in northern WA says Japan's Sumitomo could take a 22.5% stake in a $60m JV to develop the ...

There are no dead-certs in small-cap investing, but here are some plays that just might rise and shine in 2025.

Investors should ask questions about custodial-based share arrangements by which they do not have legal ownership ...

The second part of our monster list of ASX mining stock picks from fund managers and analysts around Australia.

ASX rallies on commodity boost as Brainchip and Droneshield soar, while Aussies may have splashed $1.3B on Boxing Day sales.

ASX rallies on commodity boost with BrainChip and DroneShield leading the charge, but 2025 volatility looms with key risks on ...

AI is beginning to influence yet more aspects of regular life, changing how Aussies with the right tech see the Boxing Day ...

It’s been a rocky December for investors but these stock-tipping experts still see opportunities and growth in the market.

Race Oncology hopes its repurposed drug candidate bisantrene can protect the heart from the dangerous effect of chemotherapy.